Markus D Lacher

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Escherichia Coli

Peripheral Blood

Top Venues

Human vaccines & immunotherapeutics

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Charles L Wiseman, Jarrod P Holmes, Carmen Calfa, Shaker R Dakhil, Saveri Bhattacharya, George E Peoples, Markus D Lacher, Miguel Lopez-Lago, Alex Kharazi, Giuseppe Del Priore, Mingjin Chang, Daniel L Adams, William V Williams
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer. Human vaccines & immunotherapeutics 20 (1) (2024)
Charles L Wiseman, Jarrod P Holmes, Carmen Calfa, Shaker R Dakhil, Saveri Bhattacharya, George E Peoples, Markus D Lacher, Miguel Lopez-Lago, Alex Kharazi, Giuseppe Del Priore, Mingjin Chang, Daniel L Adams, William V Williams
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer. Human vaccines & immunotherapeutics 20 (1) (2024)
Charles L Wiseman, Jarrod P Holmes, Carmen Calfa, Shaker R Dakhil, Saveri Bhattacharya, George E Peoples, Markus D Lacher, Miguel Lopez-Lago, Alex Kharazi, Giuseppe Del Priore, Mingjin Chang, Daniel L Adams, William V Williams
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer. Human vaccines & immunotherapeutics 20 (1) (2024)
Elliot Stieglitz, Christine J Gu, Michelle Richardson, Ryosuke Kita, Marianne T Santaguida, Kamran A Ali, Debbie C Strachan, Anukriti Dhar, George Yam, Wade Anderson, Erica Anderson, Juwita Hübner, Sarah K Tasian, Mignon L Loh, Markus D Lacher
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay. JCO precision oncology 7 (2023)